Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/59190
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJadhav, Rahul I-
dc.contributor.authorKedar, Nathrao A-
dc.contributor.authorChavan, Kamlesh H-
dc.date.accessioned2022-02-16T05:55:40Z-
dc.date.available2022-02-16T05:55:40Z-
dc.date.issued2022-02-
dc.identifier.issn2583-1321 (Online); 0019-5103 (Print)-
dc.identifier.urihttp://nopr.niscair.res.in/handle/123456789/59190-
dc.description184-191en_US
dc.description.abstractA series of novel N-(6-(propylthio)-1H-benzo[d]imidazol-2-yl)-aryl sulfonamide and amide derivatives have been synthesized. The structure of all newly synthesized 1H-benzo[d]imidazole derivatives have been confirmed using spectral analysis and evaluated for antibacterial, antifungal potential. Biological evaluations study reveals that the compounds 2, 3, 5, 7 and 15 are found to have moderate to good antimicrobial activity (MIC range of 10–20 mg/mL) against the bacterial strains Staphylococcus aureus ATCC 6538 and Escherichia coli ATCC 8739 in comparison to standard Ampicillin as well as fungal strains Candida albicans ATCC 10231 and Aspergillus niger ATCC 6275 in comparison to Fluconazole. These results suggest that this could be the start of an extensive medicinal chemistry program to identify the 1Hbenzo[ d]imidazole-aryl sulfonamide based potent antimicrobial agents.en_US
dc.language.isoenen_US
dc.publisherNIScPR-CSIR, Indiaen_US
dc.sourceIJC Vol.61(02) [February 2022]en_US
dc.subject1H-Benzo[d]imidazoleen_US
dc.subjectsulfonamideen_US
dc.subjectamideen_US
dc.subjectantifungalen_US
dc.subjectantibacterialen_US
dc.subjectMICen_US
dc.titleSynthesis and antimicrobial activity of novel 1H-benzo[d]imidazole-aryl sulfonamide/amide derivativesen_US
dc.typeArticleen_US
Appears in Collections:IJC Vol.61(02) [February 2022]

Files in This Item:
File Description SizeFormat 
Indian J Chem, 61, 184-191 (Feb,2022).pdf716.59 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.